Stock SLS SELLAS LIFE SCIENCES GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. SELLAS Life Sciences Group, Inc.

Equities

SLS

US81642T2096

Real-time Estimate Cboe BZX
Other stock markets
 09:58:37 27/06/2024 pm IST 		5-day change 1st Jan Change
1.125 USD +0.45% Intraday chart for SELLAS Life Sciences Group, Inc. -3.02% +6.13%
24/06 SELLAS Life Sciences Group, Inc. Announces U.S. FDA Rare Pediatric Disease Designation Granted to Sls009 for the Treatment of Pediatric Acute Lymphoblastic Leukemia CI
17/06 SELLAS Life Sciences Group, Inc. Announces Positive Recommendation from the Independent Data Monitoring Committee of the Phase 3 REGAL Trial in Acute Myeloid Leukemia CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cantor Fitzgerald Adjusts Price Target on SELLAS Life Sciences Group to $6 From $10, Keeps Overweight Rating
MT
Alliance Global Adjusts Price Target on SELLAS Life Sciences Group to $14 From $16.50, Reiterates Buy Rating
MT
Ladenburg Thalmann Starts SELLAS Life Sciences Group at Buy with $15 Price Target
MT
Maxim Group Adjusts SELLAS Life Sciences Group Price Target to $12 From $21, Maintains Buy Rating
MT
Cantor Fitzgerald Adjusts Price Target on SELLAS Life Sciences to $16 From $18, Reiterates Overweight Rating
MT
SELLAS LIFE SCIENCES : Cantor Fitzgerald Starts SELLAS Life Sciences Group at Overweight With $18 Price Target
MT
SELLAS LIFE SCIENCES : Maxim Adjusts Price Target on SELLAS Life Sciences Group to $21 From $12, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SLS Stock
  4. News SELLAS Life Sciences Group, Inc.
  5. Analyst Reco.